Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Trimethylamine N oxide, choline and its metabolites are associated with the risk of non alcoholic fatty liver disease British Journal of Nutrition Cambridge Core Pathobiological Relationship of Excessive Dietary Intake of Choline L Carnitine: A TMAO Precursor Associated Aggravation in Heart Failure in Sarcopenic Patients Identification of TMAO producer phenotype and hostdietgut dysbiosis by carnitine challenge test in human and germ free mice Gut